CMG Directional Report
Analysis based on market close March 31, 2026
Outlook
Neutral-to-bearish with a strong gravitational pull toward the $33-$32 max pain cluster, but facing headwinds from negative GEX and net selling pressure. Confidence: 6.5/10. The regime is defined by a high-volatility, trending gamma environment with spot below key pinning levels, suggesting a battle between pinning mechanics and bearish positioning.
Conflicts: Negative GEX (-$50.5M) suggests dealers hedge in the direction of price moves, amplifying trends; net premium flow is negative (-$5.6M).
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-50.5M
DEX: +27.7M shares
Gamma flip: ~$28 (Approx — based on put OI concentration of 35,710)
NTM gamma: Negative GEX implies dealers are net short gamma. A move below ~$28 flips them long gamma (hedging buy-to-close), potentially slowing a decline. A move above spot triggers sell-to-open hedging, accelerating rallies.
IV Analysis
IV vs VIX: IV 51.1% is extremely elevated — premium selling has a high implied edge, but realized vol must be managed.
Term structure: Steeply inverted near-term: 46.0% (2d) > 41.6% (10d). Major kink at 5/1 expiry (56.2%) pricing in earnings event.
Skew: The ~5 vol-point premium for 5/1 vs. surrounding expiries creates a calendar spread opportunity (sell 5/1, buy 4/17 or 4/24).
Flow Analysis
Net premium: -$5.6M net selling; P/C vol 0.75 shows put volume dominance, but OI ratio 1.06 is balanced.
Directional prints: $33C 4/24 vol 633 vs OI 147 (4.3x) at 44.2% IV — could be opening bullish call or closing short call. $34C 4/10 vol 1,427 vs OI 446 (3.2x) — similar ambiguous directional flow. The $32.50P 4/2 with low 24.4% IV suggests possible put selling for premium.
Unusual: Deep ITM $20C 4/17 with 128.9% IV and high volume — likely a synthetic long or complex roll, not a directional bet.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Moderate-Weak | N/A | Negative GEX and high IV suggest choppy, trending moves; better to sell premium against shares. |
| Short stock | Moderate | N/A | Negative GEX supports trending downside, but strong pinning to $33 and dealer long delta (DEX +) provide headwinds. |
| Covered call | Moderate-Strong | Own stock, sell $33C or $34C 4/10 or 4/17 | Assignment risk if pin breaks upside; shares called away below max pain. |
| Cash-secured put / put spread | Moderate-Strong | Sell $30P 4/17 (at put floor) or $31/$29 bear put spread 4/17 | Break below $28 support floor; high IV provides rich premium but also larger moves. |
| Long calls | Weak | N/A | Buying calls in high IV with negative GEX and net selling flow is low-probability; theta and vega decay are severe. |
| Long puts / bear put spread | Moderate | Buy $31P / sell $29P 4/17 (targeting lower EM bound) | Pinning to $33; time decay in high IV environment. |
| Iron condor | Moderate-Weak | e.g., $30P/$28P x $34C/$36C 4/17 | GEX is negative (not positive), violating a key condition for high-conviction iron condors; trending regime increases break risk. |
| Calendar/diagonal | Moderate-Strong | Reverse Calendar: Sell $33C 5/1 (56.2% IV), Buy $33C 4/17 (42.0% IV). Direction: Neutral/Bearish (theta + negative vega). | Earnings date pin risk; requires management before 4/29. |
| PMCC / LEAPS diagonal | Moderate | Buy $30C Jan 2027 (~46% IV), sell $34C 4/17 against it. | High cost basis; near-term pin may limit call premium. |
Top Plays
Watchlist Triggers
Tactical Summary
Read the Directional analysis for CMG for 2026-03-31. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.